12,900 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Purchased by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 12,900 shares of the company's stock, valued at approximately $273,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. KBC Group NV lifted its stake in shares of Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after acquiring an additional 1,577 shares in the last quarter. MeadowBrook Investment Advisors LLC increased its holdings in Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after purchasing an additional 1,460 shares during the last quarter. Empowered Funds LLC purchased a new stake in Surgery Partners during the 4th quarter worth approximately $245,000. AlphaCentric Advisors LLC acquired a new position in shares of Surgery Partners in the 4th quarter valued at approximately $374,000. Finally, Inspire Investing LLC boosted its stake in shares of Surgery Partners by 47.5% during the 4th quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock valued at $403,000 after buying an additional 6,131 shares during the last quarter.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY traded up $0.12 during trading on Friday, reaching $20.99. 815,510 shares of the company's stock traded hands, compared to its average volume of 1,099,434. The stock has a market capitalization of $2.68 billion, a P/E ratio of -43.73, a price-to-earnings-growth ratio of 19.21 and a beta of 2.40. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The company has a 50 day moving average of $23.99 and a 200-day moving average of $24.76. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Remove Ads

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. On average, equities analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Buying and Selling

In other news, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now owns 107,037 shares of the company's stock, valued at approximately $2,744,428.68. The trade was a 34.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jason Eric Evans sold 26,520 shares of the business's stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the transaction, the chief executive officer now owns 560,698 shares of the company's stock, valued at approximately $14,381,903.70. This represents a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 106,622 shares of company stock worth $2,717,860 in the last three months. 2.30% of the stock is owned by insiders.

Analyst Ratings Changes

SGRY has been the topic of a number of research analyst reports. Macquarie reduced their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. Royal Bank of Canada restated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research note on Tuesday, March 25th. Finally, Bank of America initiated coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a "buy" rating and a $30.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $36.63.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.